__timestamp | Amneal Pharmaceuticals, Inc. | Eli Lilly and Company |
---|---|---|
Wednesday, January 1, 2014 | 106735000 | 4733600000 |
Thursday, January 1, 2015 | 136870000 | 4796400000 |
Friday, January 1, 2016 | 204747000 | 5243900000 |
Sunday, January 1, 2017 | 191938000 | 5281800000 |
Monday, January 1, 2018 | 210451000 | 5051200000 |
Tuesday, January 1, 2019 | 202287000 | 5595000000 |
Wednesday, January 1, 2020 | 190585000 | 6085700000 |
Friday, January 1, 2021 | 209563000 | 7025900000 |
Saturday, January 1, 2022 | 200046000 | 7190800000 |
Sunday, January 1, 2023 | 167778000 | 9313400000 |
Monday, January 1, 2024 | 14271000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Eli Lilly and Company and Amneal Pharmaceuticals, Inc. are two prominent players, each with a distinct approach to research and development (R&D) investment. Over the past decade, Eli Lilly has consistently outpaced Amneal, investing nearly 30 times more in R&D annually. From 2014 to 2023, Eli Lilly's R&D expenses surged by approximately 97%, peaking at over $9 billion in 2023. In contrast, Amneal's investment remained relatively stable, with a modest increase of about 57% over the same period. This stark difference highlights Eli Lilly's commitment to innovation, positioning it as a leader in the pharmaceutical industry. As the demand for new treatments grows, these investments could be pivotal in shaping the future of healthcare.
Comparing Innovation Spending: Eli Lilly and Company and Novo Nordisk A/S
Research and Development Investment: Eli Lilly and Company vs argenx SE
Eli Lilly and Company or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.